Show simple item record

dc.contributor.authorMuhlis, Abdu Nafan Aisul
dc.contributor.authorMahrouseh, Nour
dc.contributor.authorSoares Andrade, Carlos Alexandre
dc.contributor.authorChen Xu, Jose
dc.contributor.authorEikemo, Terje Andreas
dc.contributor.authorBalaj, Mirza
dc.contributor.authorEconomou, Mary
dc.contributor.authorA Mechili, Enkeleint
dc.contributor.authorUnim, Brigid
dc.contributor.authorBaravelli, Carl Michael
dc.contributor.authorBadache, Andreea
dc.contributor.authorSpijker, Jeroen
dc.contributor.authorGABRANI, Jonila
dc.contributor.authorVieira, Rafael José
dc.contributor.authorLassen, Brian
dc.contributor.authorHaneef, Romana
dc.contributor.authorTecirli, Gülcan
dc.contributor.authorCuschieri, Sarah
dc.contributor.authorRojas-Rueda, David
dc.contributor.authorHoven, Hannoh
dc.contributor.authorChamouni, Ghenwa
dc.contributor.authorTarek, Gabriella Laila
dc.contributor.authorVarga, Orsolya
dc.date.accessioned2026-05-27T15:11:43Z
dc.date.available2026-05-27T15:11:43Z
dc.date.issued2026-05-07
dc.identifier.citationAisul Muhlis, Abdu Nafan; Mahrouseh, Nuor; Soares Andrade, Carlos Alexandre[et al.]. Potential impact of increasing physical activity on NCD mortality in the EU: pathways to SDG 3.4.1 by 2030. BMJ Global Health, 2026, 11(5), e022998. Disponible en <https://gh.bmj.com/content/11/5/e022998>. Fecha de acceso: 27 MAY. 2026. DOI: :10.1136/bmjgh-2025-022998ca
dc.identifier.issn2059-7908ca
dc.identifier.urihttps://hdl.handle.net/20.500.12328/5344
dc.description.abstractBackground Physical inactivity affects 36.2% of adults in the European Union (EU), contributing substantially to the burden of non-communicable diseases (NCDs). The WHO’s Global Action Plan on Physical Activity 2018–2030 targets a 15% relative reduction in physical inactivity by 2030, supporting Sustainable Development Goal (SDG) 3.4.1 to achieve over 30% reduction in premature NCD mortality. This study estimates the number of averted deaths, premature deaths and cause-specific NCD deaths averted if physical activity targets are achieved across EU countries. Methods We applied the WHO Preventable Risk Integrated ModEl using baseline physical activity and body mass index from waves 2 and 3 of the European Health Interview Survey. The counterfactual scenario modelled a 15% increase in metabolic equivalent of task hours/week of moderate-to-vigorous physical activity and a 15% relative reduction in the proportion of adults who are physically inactive across the EU. Findings Increased physical activity is associated with an estimated 24 178 premature deaths averted by 2030 (95% uncertainty interval (UI): 23 253–25 103), equivalent to 3.3% of premature NCD mortality. Overall, 107 108 deaths (95% UI: 102 479–111 737) across all ages could be prevented, representing 4.7% of total NCD deaths in EU member states. Interpretation Increasing physical activity alone is unlikely to achieve the SDG 3.4.1 target of reducing premature NCD deaths by 2030. However, when combined with other WHO ‘best buy’ interventions, such as improved diet and reduced tobacco and alcohol use, this target could be attainable across the EU.ca
dc.format.extent13ca
dc.language.isoengca
dc.publisherBMJ Publishing Groupca
dc.relation.ispartofBMJ Global Healthca
dc.relation.ispartofseries11;5
dc.rights© Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.ca
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.subject.otherIncreasing physical activityca
dc.subject.otherNCD mortality in the EUca
dc.subject.otherAumento de la actividad físicaca
dc.subject.otherMortalidad por enfermedades no transmisibles en la UEca
dc.subject.otherAugment de l'activitat físicaca
dc.subject.otherMortalitat per ECM a la UEca
dc.titlePotential impact of increasing physical activity on NCD mortality in the EU: pathways to SDG 3.4.1 by 2030ca
dc.typeinfo:eu-repo/semantics/articleca
dc.description.versioninfo:eu-repo/semantics/publishedVersionca
dc.rights.accessLevelinfo:eu-repo/semantics/openAccess
dc.embargo.termscapca
dc.subject.udc316ca
dc.identifier.doihttps://doi.org/10.1136/bmjgh-2025-022998


Files in this item

 

This item appears in the following Collection(s)

Show simple item record

© Author(s) (or their
employer(s)) 2026. Re-use
permitted under CC BY-NC. No
commercial re-use. See rights
and permissions. Published by
BMJ Group.
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc/4.0/
Share on TwitterShare on LinkedinShare on FacebookShare on TelegramShare on WhatsappPrint